PGC-1α plays a major role in the anti-apoptotic effect of 15-HETE in pulmonary artery endothelial cells

Respir Physiol Neurobiol. 2015 Jan 1:205:84-91. doi: 10.1016/j.resp.2014.10.015. Epub 2014 Oct 31.

Abstract

Peroxisome proliferator activated receptor gamma coactivator 1α (PGC-1α) has been confirmed as a key regulatory factor in pulmonary artery smooth muscle cells to mediate mitochondrial biogenesis and proliferation during hypoxia. However, the functional role of PGC-1α in hypoxic pulmonary artery endothelial cells (PAECs) still needs to be determined. In the present study, we found a marked elevation in the expression of PGC-1α under hypoxia, which was predominate in the nucleus of PAECs. This alteration of PGC-1α showed a significant association with 15-Hydroxyeicosatetraenoic acid (15-HETE), a regulator known to be protective against apoptosis at the concentration of 1 μM. By silencing PGC-1α, the action against cell viability suppression induced by 15-HETE was blocked, not only in normoxic condition but also in hypoxia-stimulated condition. Likewise, the tendency to reduce TUNEL-positive cells, abnormal nuclei and apoptotic cells in response to 15-HETE was depending on PGC-1α. Furthermore, 15-HETE and PGC-1α siRNA caused significant alterations in related mechanisms including caspase activity, mitochondrial membrane potential, and Bcl-2 expression. Taken together, these results provide the first evidence to confirm the importance of PGC-1α in mediating the protective effect of 15-HETE against apoptosis. Therefore, a clear role of PGC-1α in hypoxic PAECs is demonstrated, which may be attributed to pulmonary vascular remodeling.

Keywords: 15-HETE; Apoptosis; Hypoxia; PGC-1α; Pulmonary artery endothelial cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / physiology*
  • Blotting, Western
  • Cattle
  • Cell Hypoxia / drug effects
  • Cell Hypoxia / physiology
  • Endothelial Cells / drug effects
  • Endothelial Cells / metabolism*
  • Flow Cytometry
  • Hydroxyeicosatetraenoic Acids / metabolism*
  • Hydroxyeicosatetraenoic Acids / pharmacology
  • Immunohistochemistry
  • In Situ Nick-End Labeling
  • Muscle, Smooth, Vascular / drug effects
  • Muscle, Smooth, Vascular / metabolism
  • Pulmonary Artery / metabolism*
  • RNA, Small Interfering
  • Transcription Factors / metabolism*
  • Transfection

Substances

  • Hydroxyeicosatetraenoic Acids
  • RNA, Small Interfering
  • Transcription Factors
  • 15-hydroxy-5,8,11,13-eicosatetraenoic acid